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WHAT THIS PAPER ADDS
 Preoperative fractionated radiotherapy affects vascular healing via suppressing the development of neointima formation in the
abdominal aorta graft.
 This preliminary study can help in assessing the feasibility of expanded polytetraﬂuoroethylene (ePTFE) vascular graft recon-
struction in a prior radiation ﬁeld.a r t i c l e i n f o
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Background: Fractionated radiotherapy allows for the safe administration of larger doses without the
development of immediate or late toxicity. The inﬂuence of preoperative fractionated radiotherapy on
neointima formation for expanded polytetraﬂuoroethylene (ePTFE) graft has not been determined.
Methods: Twenty mongrel dogs were randomly divided into radiotherapy group (a total dose of 35 Gy) or
control group (no radiation). The infrarenal abdominal aorta and inferior vena cava were replaced by
ePTFE grafts at 3 months after irradiation in the radiotherapy group. Grafts were explanted at 4 weeks
after surgery. Histopathological techniques were undertaken to evaluate graft neointima formation. The
control group was managed the same as the radiotherapy group except for not receiving irradiation.
Results: Four grafts implanted into inferior vena cava in the irradiated group and three in the control
group were found to be completely occluded. None of the grafts implanted into abdominal aorta were
obstructed. In the case of the inferior vena cava graft, the thickness of the graft neointima did not differ
signiﬁcantly between the irradiated and control groups. However, for the abdominal aorta graft, the
neointima thickness in the irradiated groups was signiﬁcantly thinner than that in the control group.
Conclusion: Preoperative fractionated radiotherapy affects vascular healing via suppressing the devel-
opment of neointima formation in the abdominal aorta graft.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Incidence of postoperative complications has been increasingly
appreciated with cancer reconstruction involving previously irra-
diated ﬁelds, possibly due to vascular alterations.1 Clinical and
laboratory studies have indicated that vascular injury is a prominentThe First Afﬁliated Hospital of
g, Yunnan 650032, PR China.
ciety for Vascular Surgery. Publishefeature of both early and delayed radiation injuries, such as
inﬂammation, obliterative changes and progressive ﬁbrosis, which
increase the risk of graft failure.2 Fractionated radiotherapy allows
for the safe administration of larger doses without the development
of immediate or late toxicity.3,4 Therefore, in clinical practice,
vascular resection and reconstruction can be performed safely even
in a highly irradiated ﬁeld.5
Laboratory studies on animals, though demonstrating consid-
erable tissue damage, have shown no detectable adverse inﬂuence
of preoperative radiotherapy on the patency of anastomosedd by Elsevier Ltd. All rights reserved.
Y. Guo et al. / European Journal of Vascular and Endovascular Surgery 43 (2012) 460e465 461vessels.6,7 However, most of the previous laboratory research has
focussed on the effects of radiotherapy on venous or arterial grafts.8
The expanded polytetraﬂuoroethylene (ePTFE) grafts is widely used
in vascular surgery. In a previous study of ours, we reconstructed
large vessels in a prior irradiated ﬁeld using the ePTFE graft.9 The
results showed that irradiation at 6 weeks prior to surgery at a total
dose of 28 Gy (7 Gy  4) had no deleterious effects on ePTFE graft
patency for both infrarenal aorta and inferior vena cava (IVC). We
carried out this study to observe the effects of fractionated preop-
erative radiotherapy on the patency rate, anastomotic stoma heal-
ing, neointima formation and the covering of vascular endothelial
cells for ePTFE graft.
Methods and Materials
We used 20 adult mongrel dogs, weighing between 7 and 12 kg.
The study was approved by the Central South University Institu-
tional Animal Care and Use Committee. Animals were cared for
according to National Research Council’s Guide for the Care and Use
of Laboratory Animals (2010). A minimum of 7 days prior to irra-
diation were allowed for the dogs to acclimatise to environment of
the laboratory.
Irradiation procedure
Ten animals were picked out at random and anaesthetised
using intramuscular injection of ketamine (5 mg kg1) and intra-
venous thiamylal sodium (15 mg kg1). Median laparotomy was
performed to expose the infrarenal abdominal aorta and IVC. Two
silver clips were used as markers at the aortic bifurcation and the
left renal artery. The abdomen was then closed. Two weeks after
marking, a total dose of 35 Gy external irradiation beam irradiation
was delivered in ﬁve daily fractions of 7 Gy using a linear accel-
erator (Elekta Precise5745, Elekta AB, Sweden). Radiation direction
was right anterior/left posterior, with the angulation of 35 to the
skin, so as to keep the spinal cord away from radiated. A vascular
surgeon assisted the radiation physician in accurately locating the
radiation ﬁeld by the guidance of the clips, which was approxi-
mately 5  5 cm2, keeping the spinal cord outside of the irradiated
area.
Surgical procedure
Dogs were anaesthetised again, and intubated andmechanically
ventilated 3 months after irradiation.10 Median laparotomy was
performed to expose the infrarenal abdominal aorta and IVC.
Heparin was administered (100 U kg1). The infrarenal vena cava
was then clamped, transected and replaced with an ePTFE (Bard
Inc, Murray Hill, NJ, USA) graft that was 8 mm in diameter and 4 cm
in length. Then, the concomitant aorta was replaced with an ePTFE
graft that was 6 mm in diameter and 4 cm in length. Both proximal
and distal anastomotic stomas were performed in an end-to-end
fashion using continuous 6/0 monoﬁlament sutures. The wound
was carefully closed, and antibiotics were administered intrave-
nously during the operation. No anti-platelet drugs or heparin
therapy was administered postoperatively. With the exception of
irradiation, the same procedures were performed in the 10 dogs in
the control group.
Specimen explanted
Animals were humanly euthanised using an overdose of sodium
pentobarbital at 4 weeks after surgery. Immediately after vital signs
had ceased, the infrarenal aorta and IVC were perfusion-ﬁxed in
10% phosphate-buffered formalin at a pressure of 80e100 mmHgfor 1 h. The grafts were excised, trimmed and immersion ﬁxed in
10% phosphate-buffered formalin solution for 24 h.
Histopathology and morphometry
Specimens were opened longitudinally and the surface was
photographed. The thrombus-free surface (TFS) was calculated
using a grid, and expressed as a percentage determined by dividing
the total luminal area by the luminal area free of thrombus. Spec-
imens were then put into parafﬁn and sectioned at 4- to 5-mm
intervals, and then stained with haematoxylineeosin (HE) and
examined by an experienced observer blinded to the treatment
group. The presence of neointima and anastomotic healing was
evaluated using histopathological techniques. Sections were
imaged using an Olympus microscope equipped with a Sony
camera. The thickness of the graft neointima was measured in the
proximal, distal and the middle regions of the graft, using image-
analysis software (Image pro plus7.0, Media Cybernetics, MD, USA).
Identiﬁcation of proliferating cells and endothelial cells
Immunohistochemistry (mouse monoclonal antibody against
proliferating cell nuclear antigen (PCNA), 1:800 dilution; Zymed,
San Francisco, CA, USA) was used to detect PCNA, and thus quan-
tiﬁed the percentage of actively cycling cells within the graft neo-
intima. The canine ileum, which was known to have high rates of
proliferating cells, was used as a positive control. The PCNA index
was calculated by expressing the number of PCNA-positive cells as
a percentage of the total number of cells per high-power ﬁeld
(100). Endothelial cells (ECs) were labelled using CD31 (rabbit
polyclonal antibody against CD31, 1:200 dilution, Maixin, Fujian,
China). The CD31 index was calculated as the number of positive
cells per 100 mm on the surface of neointima (100). The canine
normal abdominal aorta was used as positive control. Tris-buffered
saline solution was used instead of the primary antibody as
a negative control. Capillary density was measured using CD31
specimens as an index of the capillary supply for the ePTFE graft
wall (number per high-power ﬁeld). Sections stained for PCNA and
CD31 were also evaluated densitometrically to quantify the inten-
sity of immunochemical reactions and conﬁrm the results.
Statistical analysis
Continuous variables were expressed as the mean  standard
deviation. Differences between the two groups were evaluated
using a one-way analysis of variance (ANOVA). Comparisons within
the same group were carried out using an ANOVA for repeated
measurements. All statistical tests were performed using the PASW
Statistic software package, version 18.0. All tests were two-tailed. p
values < 0.05 were considered statistically signiﬁcant.
Results
All animals survived and all wounds healed without complica-
tions except for one dog in the radiotherapy group which suffered
abdominal wall varicosis. This dog had an obstructed IVC graft.
There was no signiﬁcant weight loss and other adverse effects such
as oedema or lower extremity claudication after irradiation and
surgery.
Patency and Macroscopic Findings
Tissue around the graft was fragile and bled more easily in
animals in the radiotherapy group. No disunion, rupture or aneu-
rysm was observed in any of the anastomotic stoma. The overall
Table 1
Patent graft, thrombus-free area (TFS) (%), proliferating cell nuclear antigen (PCNA)
index (%), CD31 index (cells/100 mm), capillary density (%), (X S, n ¼ 10).









Patent graft 7 6 10 10
TFS 73.1  2.1 62.4  3.3a 96.7  3.2 94.2  2.6
PCNA index 28.34  4.73 30.02  3.86 18.02  2.57 12.11  2.36a
CD34 index 4.8  0.2 4.3  0.1 7.1  0.3 4.9  0.1a
Capillary
density
75.02  3.5 59.40  9.1a 84.96  4.2 62.53  8.4a
a p < 0.05 vs control.
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affected by irradiation prior to implantation. Minor thrombosis
occurred in one of the AA grafts in the radiotherapy group, but no
AA graft was obstructed. As for the IVC graft, three grafts in the
control group and four grafts in the radiotherapy groupwere totally
obstructed. Several venous collateral pathways were found to have
developed to compensate for the obstructed IVC.
For unobstructed grafts, the luminal surface was covered by
a thin smooth neointima which was white and glistening, whereas
obstructed grafts were ﬁlled with a rough red thrombus (Fig.1). The
TFS in the IVC grafts was signiﬁcantly greater (p < 0.05) in the
control group than in the radiotherapy group. However, there was
no signiﬁcant difference in the TFS in the AA grafts between the two
groups (Table 1).
Light microscopic ﬁndings
The luminal surface of the patency grafts was covered with
a smooth, thin neointima lined with a monolayer of endothelial
cells. There were no signiﬁcant differences in neointima thickness
in the IVC grafts between the control and radiotherapy groups
(Fig. 4b). However, the neointima in the AA graft at proximal,
middle and distal locations was signiﬁcantly thinner (p < 0.05) in
the radiotherapy group as compared with the control group
(Figs. 2a,b,d,e and 4a). The PCNA index was in accordance with the
HE staining results. Therewas no signiﬁcant difference between the
two groups in the case of IVC grafts. However, a higher expression
of PCNA was found in the control group than in the radiotherapy
group in the AA grafts (Table 1). CD31-positive cells were observed
primarily on the surface of the neointima and also migrated
through the interstices of the graft in the perianastomotic region, as
well as at the centre of the graft. There were no obvious differences
in the CD31 index between the two groups in the IVC grafts,
whereas the CD31 index was obviously lower (p < 0.05) in the
radiotherapy group for the AA grafts (Table 1). As compared withFigure 1. Macroscopic appearance of the ePTFE grafts. (a) Infrarenal inferior vena cava and
tissue at the time of specimen harvest. (c) The luminal surface of the patent AA graft was w
graft. Arrow: thrombosis.the control group, fewer CD31-positive cells were present in the
interstices of the graft in the radiotherapy group, in both the AA and
IVC grafts (Table 1) (Fig. 3).
Discussion
The objective of the present study was to determine whether
the patency and healing of the ePTFE graft was affected by a larger
total dose (35 Gy) of preoperative radiotherapy and a longer time
delay (3 months) before surgery. Vascular reconstruction in irra-
diated ﬁelds has been practised using free ﬂaps and results have
been favourable. In the short term, it suppressed the development
of neointima formation in the abdominal aorta graft. We did not
collect long-term effect measurement.
Radiation-induced pathological changes in vessels can be char-
acterised according to vessel size. Morphological changes in small
vessels have been described by several investigators, including
adventitial ﬁbrosis, medial hyalinisation and intimal foam cell
accumulation. Although large arteries are more radio-resistant
possibly because of their protective muscular wall composed of
less radiosensitive cells, some radiation-induced changes do occur.aorta were replaced by ePTFE graft. (b) Grafts were wrapped by fragile and bleeding
hite and glistening. (d) Red rough thrombus area located on the surface of patent IVC
Figure 2. Histological sections of the ePTFE graft (haematoxylin and eosin). (a) Neointima of the anastomosis for the AA graft in the control group. (b) Anastomosis with thinner
neointima for the AA graft in the radiotherapy group. (c) Neointima on anastomosis in the IVC graft. (40) (d) Middle of the AA graft in the control group. (e) Middle of the AA graft
with a thinner neointima in the radiotherapy group. (f) Neointima in the middle of the IVC graft. (100) Arrow: neointima, G: ePTFE graft.
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Therefore, patientswith irradiated vessel anastomosis are subject to
an increased risk of postoperative complications for vascular causes.
Although some ﬁbrosis and bleeding in vessel walls were observed
in animals in the radiotherapy group, the healing of anastomotic
stoma was not obviously affected. We speculated that this was
related to the greater radio-resistance of large vessels.13,14
In the present study, satisfactory patency and healing were
observed in the AA grafts in both groups at 4 weeks after vascularFigure 3. Inmmunohistochemical evaluation of the ePTFE graft. (a) CD-34 positive cells on
through the interstices. (c) Appearance of PCNA-positive cells in the neointima. (d) Negativ
positive cells, G: ePTFE graft.reconstruction. However, the neointimal thickness at both anasto-
moses and the midsection was signiﬁcantly thinner than in the
controls. Radiotherapy obviously suppressed neointima formation
in the AA grafts. Our analysis revealed that this may result from the
suppression of themigration and proliferation of the native vascular
smooth muscle cell (VSMC) migration.15 We observed that the
positive rate of PCNA in the AA grafts was lower in the radiotherapy
group than in the control group, which was consistent with the
decrease in the thickness of the neointima. PCNA is a ‘d’ auxiliarythe surface of the neointima. (b) CD-34 positive cells inﬁltrate in the ePTFE graft wall
e control for PCNA staining. (100) Blue arrow: CD34-positive cells, Red arrow: PCNA-
Figure 4. (a) Four weeks after surgery, neointima thickness of AA graft for radio-
therapy group was signiﬁcantly thinner than that of control group, neointima thick-
ness in the middle of the graft was thinner than proximal and distal while proximal
was thinner than distal in both groups. +p < 0.05 compared with control group,
※p < 0.05 compared with proximal and distal of the graft, *p < 0.05 compared with
distal of the graft. (b). Four weeks after surgery, there was no signiﬁcant difference for
neointima thickness between control and radiotherapy group, neointima thickness in
the middle of the graft was thinner than proximal and distal while proximal was
thicker than distal in both groups.※p < 0.05 compared with proximal and distal of the
graft, *p < 0.05 compared with distal of the graft.
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eukaryotic cells. This acidic nuclear protein is synthesised and
stored in the nucleus. The content of PCNA is low when cells are in
the G0 phase, but signiﬁcantly increases when cells enter the cell
cycle. Therefore, the expression level of PCNA reﬂects the level of
cell proliferation.16 The present study clearly demonstrated that
preoperative radiotherapy inhibited the early proliferation of the
neointima in the AA grafts, as evidenced by PCNA immunohisto-
chemistry. The mechanism whereby radiotherapy inhibits the
cellular proliferation and migration of native VSMCs may be asso-
ciated with the fact that irradiation induces a classic G1 arrest in the
cell cycle.Whether this inhibition is permanent, ormerely a delay in
the hyperplasia process, requires further study involving longer
follow-up.We also observed that the graftwall capillary densitywas
signiﬁcantly lower in the radiotherapy group, which indicated that
irradiation suppressed transmural tissue in-growth so that neo-
intima formation was partly depressed.
As for the IVC grafts, the patency in both the radiotherapy and
control groups was lower. The PCNA index and capillary densitywere consistent with the neointima thickness. We hypothesised
that the lower patency rate for the IVC graft was primarily caused
by the haemodynamic features of veins. The lower pressure, lower
ﬂow rate and lower velocity of blood in the venous system lead to
greater thrombosis formation after ePTFE graft replacement.
However, the lower radiosensitivity of veins resulted in no differ-
ence in the patency and neointima thickness between the two
groups. On the other hand, not only the differences between veins
and arteries exist in structure and function, but also the molecular
differences are established before the onset of blood ﬂow. In adult,
arterial molecular ﬁngerprints include Ephrin-B2, DLL4, CD44 and
Neuropilin-1; venous determinants include EphB4, Neuropilin-2
and COUP-TFII3.17,18 Different molecular determinants may also
play a role in the differences in between the aortic and venous
reactions. Therefore, the mechanism whereby irradiation has
different effects on the proliferation of VSMCs and transmural in-
growth in the arterial and venous needs further study.
Endothelial cells (ECs) in the ePTFE graft neointima originated in
three ways: migration of the host endothelial cells from the two
anastomoses, sedimentation of the endothelial cells or progenitor
cells from the circulation and growth of the vasa vasorum into the
vessel wall.19 As compared with the control group, capillary density
was less in the graft wall in the radiotherapy group. This may have
resulted from damage to the vasa vasorum in-growth caused by
radiation. Although ECs have generally been regarded as the most
radiosensitive cells of the vessel wall, it was hard to decidewhether
radiation injured the host ECs because there was no signiﬁcant
difference between the radiotherapy and control groups at anas-
tomoses (data not shown).
Although the source of the neointima was the same in the two
anastomoses, the proximal region was thinner in the AA grafts,
which was contrary to what was seen in the IVC grafts. The neo-
intima thickness near the anastomosis may be related to wall shear
rate distribution. Mismatches in compliance and diameter at the
end-to-end anastomosis between a compliant vessel and a rigid
graft lead to shear rate disturbances, thereby inducing intimal
hyperplasia. Since the distal side of the anastomosis ismoreprone to
intimal hyperplasia, lower shear rates near the distal anastomosis
favours the hypothesis that lowwall shear rates lead tomore intimal
hyperplasia.20 The direction of blood in the veins was contrary to
that in the artery so that the proximal neointima was thicker.Conclusion
Preoperative fractionated radiotherapymay affect vessel healing
via suppressing neointima formation in the AA grafts. Whether this
ﬁnding is clinically applicable has not been answered by this study,
and further investigation is required to ascertain the mechanism of
these observations. However, we expect that this preliminary study
can help in assessing the feasibility of ePTFE vascular graft recon-
struction in a prior radiation ﬁeld.Acknowledgements
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